Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Epilepsia ; 45(12): 1549-59, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15571513

ABSTRACT

PURPOSE: Heat shock protein-27 (HSP-27) belongs to the group of small heat shock proteins that become induced in response to various pathologic conditions. HSP-27 has been shown to protect cells and subcellular structures, particularly mitochondria, and serves as a carrier for estradiol. It is a reliable marker for tissues affected by oxidative stress. Oxidative stress and related cellular defence mechanisms are currently thought to play a major role during experimentally induced epileptic neuropathology. We addressed the question whether HSP-27 becomes induced in the neocortex resected from patients with pharmacoresistant epilepsy. METHODS: Human epileptic temporal neocortex was obtained during neurosurgery, and control tissue was obtained at autopsy from subjects without known neurologic diseases. The tissues were either frozen for Western blot analysis or fixed in Zamboni's fixative for the topographic detection of HSP-27 at the cellular level by means of immunohistochemistry. RESULTS: HSP-27 was highly expressed in all epilepsy specimens and in the cortex of a patient who died in the final stage of multiple sclerosis (positive control), whereas only low amounts of HSP-27 were detectable in control brains. In epilepsy patients, HSP-27 was present in astrocytes and in the walls of blood vessels. The intracortical distribution patterns varied strongly among the epilepsy specimens. CONCLUSIONS: These results demonstrate that HSP-27 becomes induced in response to epileptic pathology. Although the functional aspects of HSP-27 induction during human epilepsy have yet to be elucidated, it can be concluded that HSP-27 is a marker for cortical regions in which a stress response has been caused by seizures.


Subject(s)
Epilepsy/metabolism , Heat-Shock Proteins/metabolism , Temporal Lobe/chemistry , Adolescent , Adult , Aged , Astrocytes/chemistry , Astrocytes/metabolism , Biomarkers , Blood-Brain Barrier/metabolism , Blotting, Western , Child, Preschool , Epilepsy/diagnosis , Epilepsy/surgery , Female , HSP27 Heat-Shock Proteins , Heat-Shock Proteins/analysis , Humans , Immunohistochemistry , Male , Middle Aged , Molecular Chaperones , Neocortex/chemistry , Neocortex/metabolism , Neoplasm Proteins/analysis , Neoplasm Proteins/metabolism , Temporal Lobe/metabolism , Temporal Lobe/surgery , Up-Regulation
2.
Acta Neuropathol ; 108(2): 129-34, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15235806

ABSTRACT

Focal cortical dysplasias (FCD) represent a frequent finding in patients with chronic intractable epilepsy. Neuropathological hallmarks include localized dyslamination of the neocortex and neuronal heterotopias in white matter. Balloon cells, similar to those occurring in cortical tubers of patients with tuberous sclerosis (TSC) are observed in numerous patients. These lesions were classified as FCD type IIb (FCD IIb). Recent findings indicate an accumulation of TSC1 polymorphisms as well as loss of heterozygosity (LOH) and/or microsatellite instability (MSI) at the TSC1 locus on chromosome 9q in FCD IIb. Here, we tested the hypothesis of whether chromosomal instability constitutes a genome-wide phenomenon in this patient cohort. Seven microsatellite markers based on a reference panel recommended by the international workshop on microsatellite instability were analyzed in 14 surgical FCD IIb specimens. DNA from single laser-microdissected cells, i.e., balloon cells versus control neurons obtained from adjacent cortex was harvested for PCR amplification and subsequent fluorescent fragment length gel electrophoresis. Our analysis revealed only rare instances of LOH and MSI at genomic loci on 2p and 17q, whereas no alterations were found at informative markers on chromosomes 1p, 5q and 18q. In addition, no loss of repair protein expression (MSH2 or MLH1) has been identified in balloon cell nuclei of FCD IIb specimens. The present data suggest solitary LOH and MSI events at genomic localizations others than the TSC1 locus to occur in FCD IIb. Our findings lend further support to the hypothesis that the molecular pathogenesis of FCD IIb is associated with TSC1.


Subject(s)
Chromosomal Instability/physiology , Epilepsy/genetics , Tuberous Sclerosis/genetics , DNA Mutational Analysis , DNA-Binding Proteins/metabolism , Epilepsy/pathology , Humans , Immunohistochemistry/methods , Lasers , Loss of Heterozygosity/genetics , Microsatellite Repeats/genetics , MutS Homolog 2 Protein , MutS Homolog 3 Protein , Proteins/genetics , Proteins/metabolism , Proto-Oncogene Proteins/metabolism , RNA, Messenger/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction/methods , Tuberous Sclerosis/pathology , Tuberous Sclerosis Complex 1 Protein , Tumor Suppressor Proteins
3.
Acta Neuropathol ; 108(4): 272-8, 2004 Oct.
Article in English | MEDLINE | ID: mdl-15221338

ABSTRACT

Balloon cells are histopathological hallmarks of various cortical malformations, i.e., focal cortical dysplasia (Taylor's type, FCD IIb), hemimegalencephaly (HME) or cortical tubers (tuberous sclerosis, TSC). Whether this intriguing cell type results from similar pathogenetic pathways remains to be shown. Here, we analyzed the immunohistochemical distribution pattern of the CD34 epitope in surgical specimens from 34 patients with FCD IIb, compared to that of 6 patients with TSC and 3 patients with HME. In normal brain, CD34 occurs only transiently during neurulation, but cannot be detected in mature neuroectodermal cell progenies. In contrast, 58% of our patients showed CD34 immunoreactivity within a subpopulation of balloon cells. Interestingly, CD34-positive balloon cells were confined to the white matter, but never observed in neocortical layers. Furthermore, balloon cells expressing neurofilament protein were also restricted to white matter, whereas GFAP-positive balloon cells were observed either in white or gray matter location. Clinical characteristics did not significantly differ between patients with CD34-positive versus CD34-negative lesions. No significant correlation was found between CD34 expression and genetic alterations of the TSC1 gene, which is affected in many FCD and TSC patients and which plays a role in the regulation of cell size. Further studies are warranted to clarify the restricted expression of CD34 in balloon cells of the white matter.


Subject(s)
Antigens, CD34/metabolism , Brain Diseases/metabolism , Brain Diseases/pathology , Cerebral Cortex/abnormalities , Adolescent , Brain Diseases/genetics , Cerebral Cortex/metabolism , Child , Child, Preschool , Genotype , Humans , Immunohistochemistry , Infant , Infant, Newborn , Loss of Heterozygosity , Phenotype , Seizures/etiology , Tuberous Sclerosis/genetics , Tuberous Sclerosis/metabolism , Tuberous Sclerosis/pathology
4.
Epilepsia ; 43(12): 1480-7, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12460248

ABSTRACT

PURPOSE: The anticonvulsant effects of the novel antiepileptic drug (AED) levetiracetam (LEV) were tested in neocortical slice preparations from 23 patients who underwent surgery for the treatment of refractory epilepsy. METHODS: Slices were used to evaluate the effects of LEV on two different models of epilepsy: low-Mg2+-induced untriggered and bicuculline-evoked stimulus-triggered epileptiform burst discharges and spontaneously appearing rhythmic sharp waves. RESULTS: LEV (0.1-1 mM) did not influence spontaneously appearing rhythmic sharp waves or Mg2+-free aCSF-induced epileptiform field potentials. LEV affected neither the amplitudes or duration nor the repetition rates of burst discharges in these epilepsy models. However, LEV (100-500 microM) significantly suppressed the ictal-like discharges elicited by the gamma-aminobutyric acid subtype A (GABAA)-receptor antagonist bicuculline. A marked reduction of the amplitude and duration of bicuculline-evoked field response in the presence of LEV was observed. CONCLUSIONS: The results indicate the potential for LEV to inhibit epileptiform burst discharges in human neocortical tissue, which is consistent with its effects in animal models of epilepsy. These results also support the seizure reduction observed in clinical trials and support that this may, in part, be related to the ability of LEV to inhibit epileptiform discharges.


Subject(s)
Anticonvulsants/pharmacology , Bicuculline/analogs & derivatives , Electroencephalography/drug effects , Epilepsy/physiopathology , Neocortex/drug effects , Piracetam/analogs & derivatives , Piracetam/pharmacology , Adolescent , Adult , Bicuculline/pharmacology , Child , Child, Preschool , Culture Media , Culture Techniques , Electric Stimulation , Evoked Potentials/drug effects , Female , Humans , Infant , Levetiracetam , Magnesium/physiology , Male , Middle Aged , Neocortex/physiopathology
5.
Epilepsia ; 43(11): 1379-84, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12423388

ABSTRACT

PURPOSE: To determine whether dysembryoplastic neuroepithelial tumors (DNTs) that belong to the neuronal migration disorders (NMDs) are to be classified with them or with "other low-grade brain tumors" regarding several etiologic, clinical, magnetic resonance imaging (MRI), and EEG findings. METHODS: These findings of 21 DNT patients were compared with those of 13 consecutive patients with other low-grade brain tumors and 41 NMD patients. RESULTS: The result is absolutely clear: nearly all findings in DNT patients (complications during pregnancy, birth, the newborn period and the postnatal period, age at first seizure, epileptic syndrome, seizure type, febrile seizures, retarded milestones, intellectual and neurologic deficits, MRI, interictal and ictal EEG findings) being similar or in agreement with those of other low-grade brain tumors, not with those of other NMDs. CONCLUSIONS: Regarding various clinical features including surgery outcome, MRI, and EEG findings, DNTs should be classified with the other low-grade brain tumors, rather than with NMDs.


Subject(s)
Brain Neoplasms/complications , Brain/abnormalities , Epilepsy/etiology , Epilepsy/surgery , Neoplasms, Neuroepithelial/complications , Teratoma/complications , Adolescent , Adult , Brain Neoplasms/classification , Child , Child, Preschool , Electroencephalography , Epilepsy/diagnosis , Humans , Magnetic Resonance Imaging , Neoplasms, Neuroepithelial/classification , Teratoma/classification
6.
Ann Neurol ; 52(1): 29-37, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12112044

ABSTRACT

Focal cortical dysplasia (FCD) is characterized by a localized malformation of the neocortex and underlying white matter. Balloon cells, similar to those observed in tuberous sclerosis, are present in many cases (FCD(bc)). In these patients, a hyperintense funnel-shaped subcortical lesion tapering toward the lateral ventricle was the characteristic finding on fluid-attenuated inversion recovery magnetic resonance imaging scans. Surgical lesionectomy results in complete seizure relief. Although the pathogenesis of FCD(bc) remains uncertain, histopathological similarities indicate that FCD(bc) may be related pathogenetically to tuberous sclerosis. Here, we studied alterations of the TSC1 and TSC2 genes in a cohort of patients with chronic, focal epilepsy and histologically documented FCD(bc) (n = 48). DNA was obtained after microdissection and laser-assisted isolation of balloon cells, dysplastic neurons, and nonlesional cells from adjacent normal brain tissue. Sequence alterations resulting in amino acid exchange of the TSC1 gene product affecting exons 5 and 17 and silent base exchanges in exons 14 and 22 were increased in patients with FCD(bc) compared with 200 control individuals (exon 5, 2.3% FCD(bc) vs 0% C; exon 17, 35% FCD(bc) vs 1.0% C; exon 14, 37.8% FCD(bc) vs 15% C; exon 22, 45% FCD(bc) vs 23.8% C). Sequence alterations could be detected in FCD(bc) and in adjacent normal cells. In 24 patients, DNA was suitable to study loss of heterozygosity at the TSC1 gene locus in microdissected FCD(bc) samples compared with control tissue. Eleven FCD(bc) cases exhibited loss of heterozygosity. In the TSC2 gene, only silent polymorphisms were detected at similar frequencies as in controls. Our findings indicate that FCD(bc) constitutes a clinicopathological entity with distinct neuroradiological, neuropathological, and molecular genetic features. These data also suggest a role of the TSC1 gene in the development of FCD(bc) and point toward a pathogenic relationship between FCD(bc) and the tuberous sclerosis complex.


Subject(s)
Neocortex/pathology , Proteins/genetics , Tuberous Sclerosis/genetics , Tuberous Sclerosis/pathology , Amino Acid Substitution/genetics , DNA/isolation & purification , DNA Mutational Analysis , Dissection , Epilepsy/genetics , Epilepsy/pathology , Epilepsy/surgery , Humans , Lasers , Loss of Heterozygosity/genetics , Polymerase Chain Reaction , Polymorphism, Genetic/genetics , Tuberous Sclerosis/surgery , Tuberous Sclerosis Complex 1 Protein , Tumor Suppressor Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...